Key facts
- iO-CO IP’s last known valuation is $25.1M (Feb 2026).
- It has raised $3.8M; the latest was Seed Round ($3.6M) in Feb 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for iO-CO IP
- ·The full record, as it builds
Funding rounds
No funding rounds for iO-CO IP are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About iO-CO IP
Developer of behavioral neuroscience-based technology and products designed for human behavior research into product development and venture creation. The company conducts applied research on areas such as sleep, stress, cognition, and health patterns, processes scientific findings into structured insights, develops intellectual property from research outputs, supports product design and prototyping, and facilitates venture creation through commercialization frameworks, enabling healthcare and consumer technology developers to utilize scientifically grounded insights for building products aligned with human behavioral patterns and improving functional outcomes.
- Sector
- Healthcare
- HQ
- Berkshire, United Kingdom
- Founded
- 2017
- Employees
- 3
- Website
- io-co.io/
- Ownership
- Privately Held (backing)
iO-CO IP doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in iO-CO IP shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on iO-CO IP in its N-PORT filings yet. We sweep new filings monthly.